Combination with lenalidomide in adult patients with relapsed or refractory diffuse large B-cell lymphoma(DLBCL) who are not eligible for autologous stem cell transplant(ASCT) and failed one or more prior therapies, followed by this drug monotherapy.
Mircera is an erythropoiesis-stimulating agent (ESA) indicated for the treatment of anemia associated with chronic kidney disease (CKD in adult patients on dialysis and patients not on dialysis